Compare PRCT & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRCT | BXMX |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2021 | N/A |
| Metric | PRCT | BXMX |
|---|---|---|
| Price | $28.88 | $14.79 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $51.13 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 205.6K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $299,907,000.00 | N/A |
| Revenue This Year | $48.30 | N/A |
| Revenue Next Year | $29.44 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.07 | N/A |
| 52 Week Low | $27.80 | $11.75 |
| 52 Week High | $75.29 | $13.75 |
| Indicator | PRCT | BXMX |
|---|---|---|
| Relative Strength Index (RSI) | 38.93 | 60.18 |
| Support Level | $28.76 | $14.63 |
| Resistance Level | $31.35 | $14.82 |
| Average True Range (ATR) | 1.52 | 0.14 |
| MACD | -0.17 | -0.00 |
| Stochastic Oscillator | 7.94 | 84.09 |
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.